quinapril has been researched along with Cardiac Failure in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (8.20) | 18.7374 |
| 1990's | 35 (57.38) | 18.2507 |
| 2000's | 17 (27.87) | 29.6817 |
| 2010's | 3 (4.92) | 24.3611 |
| 2020's | 1 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Aronow, WS; Barkhordarian, M; Erbay, MI; Gupta, R; Lawrence, JA; Ulusan, S | 1 |
| Booij, HG; Damman, K; Rouleau, JL; van Gilst, WH; Warnica, JW; Westenbrink, BD | 1 |
| Kanorskiy, SG; Pokrovskiy, VM; Tregubov, VG | 1 |
| Batlouni, M; Magalhães, HM; Piegas, LS; Savioli Neto, F | 1 |
| Kanorskiĭ, SG; Pokrovskiĭ, VM; Tregubov, VG | 1 |
| Bicket, DP | 1 |
| Gadzhiev, AN | 1 |
| Carmichael, N; Lye, M; Zi, M | 1 |
| Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV | 1 |
| Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Skvortsov, AA; Sychev, AV | 2 |
| Brower, GL; Janicki, JS; Levick, SP | 1 |
| Plosker, GL; Sorkin, EM | 1 |
| Bahrmann, H; Brunner, HR; Delius, W; Fleck, E; Nussberger, J; Schultheiss, HP | 1 |
| Campana, C; Gavazzi, A; Marioni, R; Montemartini, C | 1 |
| Hillis, WS; Lees, KR; Macfadyen, RJ; Reid, JL; Squire, IB | 1 |
| Davies, M; Doran, J; Jones, S; Townend, J | 1 |
| Bammert-Adams, JA; Begg, EJ; Ikram, H; Olson, SC; Posvar, EL; Reece, PA; Richards, AM; Robson, RA; Sedman, AJ | 1 |
| Binder, SB | 1 |
| Baird, MG; DiBianco, R; Pflugfelder, PW; Pitt, B; Tonkon, MJ | 1 |
| Borghi, A; Bugiardini, R; Cianfrocca, C; Morgagni, GL; Pelliccia, F; Ruggeri, A | 1 |
| Bain, RJ; Davies, MK; Lawson, N; Qiang, FX; Townend, JN; Virk, SJ | 1 |
| Dargie, HJ; Elder, AT; Henderson, E; Lahiri, A; Northridge, DB; Raftery, ED; Rose, E; Shaw, TR | 1 |
| Kersten, U; Morisse, B | 1 |
| Bourdarias, JP; Dib, JC; Dubourg, O; Jondeau, G | 1 |
| Beynon, JH; Pathy, MS | 1 |
| Hamer, A; Hare, D; Howes, LG; Jackson, B; Karrasch, J; Krum, H; Leslie, P | 1 |
| Agnoletti, L; Bachetti, T; Comini, L; Curello, S; Ferrari, R | 1 |
| Bastien, N; Lambert, C | 1 |
| Fleishman, S; Georges, JL; Gunduz, H | 1 |
| Bocan, TM; Li, H; Peterson, JT; Simon, H | 1 |
| Kawai, H; Liang, CS; Stevens, SY | 1 |
| Corbera, JA; Martinez-Alcaine, MA; Montoya, JA; Ynaraja, E | 1 |
| Francis, GS; Gassler, JP | 1 |
| Lawrie, MM | 1 |
| Cernacek, P; Nguyen, QT; Picard, P; Qi, XL; Rouleau, JL; Sia, YT; Sirois, M; Stewart, DJ; Wei, G | 1 |
| Aizawa, Y; Fuse, K; Hanawa, H; Inoue, M; Kodama, M; Kouda, T; Ma, M; Nakazawa, M; Ohta, Y; Sekiguchi, T; Wahed, MI; Watanabe, K; Yamamoto, T; Yoshida, Y | 1 |
| Dienesch, C; Horn, M; Hügel, S; Neubauer, S; Remkes, H | 1 |
| Liu, P; Qu, R; Roulea, JL; Siroi, MG; We, GC | 1 |
| Davies, MK; Littler, WA; Townend, JN; West, JN | 1 |
| Fisher, ML; Gottlieb, SS; Krichten, CM; Robinson, S; Weir, MR | 1 |
| Frank, GJ; Knapp, LE; Olson, SC; Phelps, MC; Quade, MM; Rieger, MM; Sedman, AJ | 1 |
| Kupari, M; Nieminen, MS | 1 |
| Riegger, GA | 2 |
| Frank, GJ; Knapp, LE; McLain, R; Posvar, E; Rieger, MM; Singer, R | 1 |
| Elsner, D; Kromer, EP; Riegger, GA | 1 |
| Chance, M; Green, JA; Munger, MA; Nair, R; Nara, AR; Posvar, EL; Prescott, AW; Simonson, MS | 1 |
| Bousley, RF; Haleen, SJ; Keiser, JA; Overhiser, RW; Rapundalo, SR; Taylor, DG; Weishaar, RE | 1 |
| Cetnarowski-Cropp, AB | 1 |
| Franchi, F; Puddu, GM | 1 |
| Frank, GJ | 2 |
| Canter, D; Frank, GJ; Knapp, LE; McLain, RW | 1 |
| Dargie, HJ; Northridge, DB | 1 |
| Posvar, E; Sedman, AJ | 1 |
| Frank, GJ; Knapp, LE; McLain, RW | 1 |
| Banas, JS | 1 |
| Holt, P; Najm, J; Sowton, E | 1 |
13 review(s) available for quinapril and Cardiac Failure
| Article | Year |
|---|---|
Benefit and risk evaluation of quinapril hydrochloride.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 2023 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Models, Animal; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Isoquinolines; Kidney; Male; Quinapril; Tetrahydroisoquinolines | 1994 |
ACE inhibitors: review of four new agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Fosinopril; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Ramipril; Tetrahydroisoquinolines | 1993 |
Endothelial function and dysfunction in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Endothelium, Vascular; Heart Failure; Humans; Isoquinolines; Nitric Oxide; Nitric Oxide Synthase; Quinapril; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha; Vasodilation | 1998 |
Effect of treatment on survival in an animal model of chronic heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cricetinae; Disease Models, Animal; Heart Failure; Humans; Isoquinolines; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines | 1998 |
Overview of quinapril, a new ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Europe; Heart Failure; Hemodynamics; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines; United States | 1990 |
Quinapril: a new second-generation ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Interactions; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1991 |
[ACE inhibitors and heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Isoquinolines; Lisinopril; Quinapril; Tetrahydroisoquinolines | 1990 |
Overview of the clinical development of quinapril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Evaluation; Heart Failure; Humans; Hypertension; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1990 |
The safety profile of quinapril: is there a difference among ACE inhibitors?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Drug Evaluation; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Safety; Tetrahydroisoquinolines | 1990 |
Quinapril in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isoquinolines; Physical Exertion; Quinapril; Tetrahydroisoquinolines; Vascular Resistance | 1990 |
Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Quinapril; Tetrahydroisoquinolines; Time Factors | 1989 |
24 trial(s) available for quinapril and Cardiac Failure
| Article | Year |
|---|---|
β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Double-Blind Method; Female; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Quinapril; Risk Factors; Stroke; Tetrahydroisoquinolines | 2015 |
ACE inhibitors and plasma B-type natriuretic peptide levels in elderly patients with heart failure.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatine; Dose-Response Relationship, Drug; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Natriuretic Peptide, Brain; Prospective Studies; Quinapril; Tetrahydroisoquinolines; Urea; Walking | 2009 |
[Advantages of quinapril therapy in patients with arterial hypertension and functional class III chronic heart failure with preserved left ventricular ejection fraction].
Topics: Antihypertensive Agents; Biological Availability; Blood Pressure; Drug Monitoring; Female; Heart Failure; Humans; Hypertension; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Quinapril; Renin-Angiotensin System; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Function, Left | 2012 |
The effect of quinapril on functional status of elderly patients with diastolic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diastole; Double-Blind Method; Female; Heart Failure; Humans; Male; Quality of Life; Quinapril; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left; Walking | 2003 |
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Renin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2005 |
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Bisoprolol; Drug Therapy, Combination; Electrocardiography, Ambulatory; Follow-Up Studies; Heart Failure; Humans; Quinapril; Severity of Illness Index; Stroke Volume; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Bisoprolol; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Quality of Life; Quinapril; Stroke Volume; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Models, Animal; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Isoquinolines; Kidney; Male; Quinapril; Tetrahydroisoquinolines | 1994 |
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Male; Middle Aged; Neurotransmitter Agents; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines; Ventricular Function, Left | 1994 |
Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
Topics: Aged; Captopril; Double-Blind Method; Echocardiography; Electrocardiography; Female; Heart Failure; Humans; Isoquinolines; Male; Middle Aged; Physical Exertion; Quinapril; Tetrahydroisoquinolines | 1994 |
Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Quinapril; Renin; Tetrahydroisoquinolines | 1994 |
Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Isoquinolines; Linear Models; Male; Middle Aged; Quinapril; Substance Withdrawal Syndrome; Tetrahydroisoquinolines | 1993 |
A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Exercise Tolerance; Female; Heart Failure; Humans; Isoquinolines; Male; Middle Aged; Quality of Life; Quinapril; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome | 1993 |
[Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1995 |
An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Female; Heart Failure; Humans; Isoquinolines; Male; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines; Walking | 1997 |
Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Drug Administration Schedule; Female; Heart Failure; Humans; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1998 |
The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Isoquinolines; Male; Middle Aged; Multicenter Studies as Topic; Quinapril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 1990 |
The safety and tolerability of quinapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Male; Middle Aged; Potassium; Quinapril; Tetrahydroisoquinolines | 1990 |
Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Digoxin; Drug Therapy, Combination; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Hydrochlorothiazide; Isoquinolines; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Quinapril; Randomized Controlled Trials as Topic; Renin; Single-Blind Method; Tetrahydroisoquinolines | 1990 |
Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Isoquinolines; Long-Term Care; Male; Quinapril; Tetrahydroisoquinolines | 1991 |
Overview of the clinical development of quinapril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Evaluation; Heart Failure; Humans; Hypertension; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1990 |
Quinapril in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isoquinolines; Physical Exertion; Quinapril; Tetrahydroisoquinolines; Vascular Resistance | 1990 |
Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Topics: Adolescent; Adult; Aged; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Multicenter Studies as Topic; Peptidyl-Dipeptidase A; Quinapril; Random Allocation; Tetrahydroisoquinolines | 1989 |
Overall tolerance and safety of quinapril in clinical trials.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Isoquinolines; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1989 |
27 other study(ies) available for quinapril and Cardiac Failure
| Article | Year |
|---|---|
[Regulatory Adaptive Status in Assessment of Efficacy of Pharmacotherapy and Prognostication of Complications in Functional Class III Chronic Heart Failure].
Topics: Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Quinapril; Random Allocation; Spironolactone; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Function, Left | 2016 |
[Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Isoquinolines; Middle Aged; Quinapril; Tetrahydroisoquinolines; Treatment Outcome | 2003 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
[The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Isoquinolines; Myocardial Infarction; Quinapril; Tetrahydroisoquinolines | 1993 |
Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Creatinine; Endothelins; Female; Heart Failure; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Norepinephrine; Pulmonary Artery; Pulmonary Wedge Pressure; Quinapril; Renin; Stroke Volume; Tetrahydroisoquinolines; Vascular Resistance | 1994 |
The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Aging; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Half-Life; Heart Failure; Humans; Isoquinolines; Kidney Function Tests; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1994 |
Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Function, Right; Blood Pressure; Cardiac Output; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Lung; Male; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure; Quinapril; Stroke Volume; Tetrahydroisoquinolines; Time Factors; Vascular Resistance; Vasodilation | 1993 |
Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Dobutamine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Lymphocytes; Male; Middle Aged; Quinapril; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Up-Regulation | 1993 |
Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arm; Coronary Circulation; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Hyperemia; Isoquinolines; Leg; Male; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Physical Exertion; Quinapril; Regional Blood Flow; Respiration; Stroke Volume; Tetrahydroisoquinolines; Vasodilation; Ventricular Dysfunction, Left | 1997 |
Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Endothelium, Vascular; Heart Failure; Humans; Isoquinolines; Peptidyl-Dipeptidase A; Quinapril; Tetrahydroisoquinolines; Vasodilation | 1998 |
Quinapril and depression.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Depressive Disorder; Heart Failure; Humans; Hypertension; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1999 |
MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Blotting, Western; Collagen; Collagenases; Enzyme Inhibitors; Heart Failure; Hydroxamic Acids; Isoquinolines; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Myocardium; Oligopeptides; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WF; Tetrahydroisoquinolines; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases | 2000 |
Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Fluorescent Antibody Technique; Heart; Heart Failure; Hemodynamics; Isoquinolines; Losartan; Neurons; Norepinephrine; Pacemaker, Artificial; Presynaptic Terminals; Quinapril; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase; Ventricular Function, Left | 2000 |
Effect of short-term treatment with bumetanide, quinapril and low-sodium diet on dogs with moderate congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bumetanide; Diet, Sodium-Restricted; Diuretics; Dog Diseases; Dogs; Female; Heart Failure; Isoquinolines; Male; Mitral Valve Insufficiency; Prospective Studies; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines; Treatment Outcome | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
ACE inhibitors for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines; Treatment Outcome | 2001 |
Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: effects of chronic quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Binding, Competitive; Body Weight; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Heart Failure; Hemodynamics; Isoquinolines; Kinetics; Male; Muscles; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligopeptides; Organ Culture Techniques; Organ Size; Papillary Muscles; Peptides, Cyclic; Piperidines; Protein Binding; Quinapril; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydroisoquinolines; Time Factors; Vasoconstrictor Agents; Viper Venoms | 2001 |
Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Heart Failure; Isoquinolines; Male; Myocarditis; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatine Kinase; Disease Models, Animal; Energy Metabolism; Heart Failure; Isoquinolines; Magnetic Resonance Spectroscopy; Myocardial Infarction; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Remodeling | 2001 |
Effects of quinapril on myocardial function, ventricular remodeling and cardiac cytokine expression in congestive heart failure in the rat.
Topics: Animals; Cytokines; Heart Failure; Hemodynamics; Isoquinolines; Male; Myocardial Infarction; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Remodeling | 2002 |
Effect of quinapril on blood pressure and heart rate in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Norepinephrine; Quinapril; Renin; Signal Processing, Computer-Assisted; Tetrahydroisoquinolines | 1992 |
Determinants of the renal response to ACE inhibition in patients with congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Heart Failure; Humans; Isoquinolines; Kidney; Kidney Function Tests; Male; Middle Aged; Quinapril; Renal Circulation; Renin; Renin-Angiotensin System; Risk Factors; Tetrahydroisoquinolines | 1992 |
The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Exercise; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1990 |
Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.
Topics: Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Isoquinolines; Liver Circulation; Male; Quinapril; Regional Blood Flow; Renal Circulation; Stroke Volume; Tetrahydroisoquinolines; Ventricular Function, Left | 1992 |
Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Coronary Circulation; Cricetinae; Heart; Heart Failure; Hemodynamics; In Vitro Techniques; Isoquinolines; Mesocricetus; Myocardial Contraction; Peptidyl-Dipeptidase A; Perfusion; Quinapril; Tetrahydroisoquinolines | 1991 |
Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1989 |
The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Catheterization; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoquinolines; Male; Middle Aged; Pulmonary Circulation; Quinapril; Tetrahydroisoquinolines | 1986 |